Cargando…
Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT(1A) receptor mediated Akt/GSK-3β pathway
Tau hyperphosphorylation is an important pathological feature of Alzheimer's disease (AD). To investigate whether escitalopram could inhibit amyloid-β (Aβ)-induced tau hyperphosphorylation and the underlying mechanisms, we treated the rat primary hippocampal neurons with Aβ(1-42) and examined t...
Autores principales: | Wang, Yan-Juan, Ren, Qing-Guo, Gong, Wei-Gang, Wu, Di, Tang, Xiang, Li, Xiao-Li, Wu, Fang-Fang, Bai, Feng, Xu, Lin, Zhang, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924645/ https://www.ncbi.nlm.nih.gov/pubmed/26950279 http://dx.doi.org/10.18632/oncotarget.7798 |
Ejemplares similares
-
Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice
por: Wu, Beibei, et al.
Publicado: (2015) -
Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023) -
Systemic attenuation of the TGF-β pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal
por: Yousef, Hanadie, et al.
Publicado: (2015) -
TGF-β1-Smad signaling pathways are not required for epidermal LC homeostasis
por: Li, Guihua, et al.
Publicado: (2016) -
GULP1/CED-6 ameliorates amyloid-β toxicity in a Drosophila model of Alzheimer’s disease
por: Vivien Chiu, Wai Yin, et al.
Publicado: (2017)